Agios Pharm Stock Target Price and Analyst Consensus
| AGIO Stock | USD 34.54 0.81 2.40% |
The current analyst and expert consensus on Agios Pharm is Buy, with 3 strong buy opinions. The current projected Agios Pharm target price consensus is 57.00 with 9 analyst opinions. Check out Macroaxis Advice on Agios Pharm to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.The most common way Agios Pharm analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Agios Pharm executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Agios Pharm. We strongly encourage you to use your own analysis of Agios Pharm to validate this buy or sell advice. Agios Pharm buy-or-sell recommendation module provides average expert sentiment on the projected Agios Pharm target price to derive its highest and lowest estimates based on projected price volatility of 4.8474.
Lowest Forecast 51.87 | Highest Forecast 63.27 | Target Price 57 |
Agios |
It's important to approach Agios Pharm's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Agios Pharm Target Price Consensus
Agios target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Agios Pharm's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 9 | Buy |
Most Agios analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Agios stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Agios Pharm, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAgios Pharm Target Price Projection
Agios Pharm's current and average target prices are 34.54 and 57.00, respectively. The current price of Agios Pharm is the price at which Agios Pharm is currently trading. On the other hand, Agios Pharm's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Agios Pharm Market Quote on 31st of January 2025
Target Price
Analyst Consensus On Agios Pharm Target Price
Agios Pharm Analyst Ratings
Agios Pharm's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Agios Pharm stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Agios Pharm's financials, market performance, and future outlook by experienced professionals. Agios Pharm's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Agios Pharm price targets
Agios Pharm's stock target price is an estimate of its future price, usually made by analysts. Using Agios Pharm's target price to determine if it is a suitable investment can be done through the following steps:- Look at Agios Pharm's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Agios Pharm's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Agios Pharm Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Agios Pharm is a key component of Agios Pharm valuation and have some predictive power on the future returns of a Agios Pharm.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Investor Favorites Invested over 300 shares | |
 | Driverless Cars Invested over 50 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Social Domain Invested few shares | |
 | Banking Invested over 30 shares | |
 | Baby Boomer Prospects Invested over 60 shares | |
 | Business Services Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Momentum Invested over 60 shares | |
 | Manufacturing Invested over 30 shares | |
 | Artificial Intelligence Invested few shares |
Check out Macroaxis Advice on Agios Pharm to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.